Login Register Cart 0
Generic placeholder image

Current Neurovascular Research

Editor-in-Chief

ISSN (Print): 1567-2026
ISSN (Online): 1875-5739

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

The Study of Risk Factors and The Predict Model of Cerebral Microbleeds

Author(s): Tao Lv* and Changqing Li

Volume 20, Issue 3, 2023

Published on: 24 August, 2023

Page: [377 - 389] Pages: 13

DOI: 10.2174/1567202620666230710160809

Price: $65

Abstract

Background: To determine the association of cardiovascular risk factors with the presence and anatomic location of CMBs and construct a factor-based evaluating model to predict a high CMBs burden.

Methods: We assessed the relation of age, male, various cardiovascular risk factors, medication use, stroke histories and white matter hyperintensities (WMH) to the presence and location of CMBs with univariate analysis and multiple logistic regression. Finally, we added risk factors for a high CMBs burden to a factor-based evaluating model score.

Results: 485 patients were included in our study. CMBs were more prevalent with advanced age, male sex, more cardiovascular risk factors and WMH. Alcohol use, hemorrhagic stroke history and the degree of deep white matter hyperintensity (DWMH) were independent predictors for a high CMBs burden (≥10). We finally structured a prediction model-HPSAD3 that consisted of hypertension, alcohol use, hemorrhagic stroke history and WMH to predict a high CMBs burden. The model-HPSAD3 has a higher positive predict value (77.08%) and negative predict value (75.89%) to predict a high CMBs burden when the cut-off score is 4.

Conclusions: Hypertension, alcohol use, hemorrhagic stroke history and WMH were added into the model- HPSAD3, and there was a higher possibility of patients with CMBs ≥10 when the score of HPSAD3 ≥4.

« Previous Next »
[1]
Pantoni L. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9(7): 689-701.
[http://dx.doi.org/10.1016/S1474-4422(10)70104-6] [PMID: 20610345]
[2]
Charidimou A, Pantoni L, Love S. The concept of sporadic cerebral small vessel disease: A road map on key definitions and current concepts. Int J Stroke 2016; 11(1): 6-18.
[http://dx.doi.org/10.1177/1747493015607485] [PMID: 26763016]
[3]
Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12(8): 822-38.
[http://dx.doi.org/10.1016/S1474-4422(13)70124-8] [PMID: 23867200]
[4]
Jeerakathil T, Wolf PA, Beiser A, et al. Cerebral microbleeds. Stroke 2004; 35(8): 1831-5.
[http://dx.doi.org/10.1161/01.STR.0000131809.35202.1b] [PMID: 15155954]
[5]
Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: A guide to detection and interpretation. Lancet Neurol 2009; 8(2): 165-74.
[http://dx.doi.org/10.1016/S1474-4422(09)70013-4] [PMID: 19161908]
[6]
Sperling RA, Jack CR Jr, Black SE, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s association research roundtable workgroup. Alzheimers Dement 2011; 7(4): 367-85.
[http://dx.doi.org/10.1016/j.jalz.2011.05.2351] [PMID: 21784348]
[7]
Sveinbjornsdottir S, Sigurdsson S, Aspelund T, et al. Cerebral microbleeds in the population based AGES-Reykjavik study: Prevalence and location. J Neurol Neurosurg Psychiatry 2008; 79(9): 1002-6.
[http://dx.doi.org/10.1136/jnnp.2007.121913] [PMID: 18270235]
[8]
Haller S, Vernooij MW, Kuijer JPA, Larsson EM, Jäger HR, Barkhof F. Cerebral microbleeds: Imaging and clinical significance. Radiology 2018; 287(1): 11-28.
[http://dx.doi.org/10.1148/radiol.2018170803] [PMID: 29558307]
[9]
Vernooij MW, Haag MD, van der Lugt A, et al. Use of antithrombotic drugs and the presence of cerebral microbleeds: The Rotterdam Scan Study. Arch Neurol 2009; 66(6): 714-20.
[http://dx.doi.org/10.1001/archneurol.2009.42] [PMID: 19364926]
[10]
Gregoire SM, Jäger HR, Yousry TA, Kallis C, Brown MM, Werring DJ. Brain microbleeds as a potential risk factor for antiplatelet-related intracerebral haemorrhage: Hospital-based, case-control study. J Neurol Neurosurg Psychiatry 2010; 81(6): 679-84.
[http://dx.doi.org/10.1136/jnnp.2009.198994] [PMID: 20522874]
[11]
Lau KK, Wong YK, Teo KC, et al. Long‐term prognostic implications of cerebral microbleeds in Chinese patients with ischemic stroke. J Am Heart Assoc 2017; 6(12): e007360.
[http://dx.doi.org/10.1161/JAHA.117.007360] [PMID: 29217662]
[12]
Fiehler J. Cerebral microbleeds: Old leaks and new haemorrhages. Int J Stroke 2006; 1(3): 122-30.
[http://dx.doi.org/10.1111/j.1747-4949.2006.00042.x] [PMID: 18706032]
[13]
Graff-Radford J, Simino J, Kantarci K, et al. Neuroimaging correlates of cerebral microbleeds. Stroke 2017; 48(11): 2964-72.
[http://dx.doi.org/10.1161/STROKEAHA.117.018336] [PMID: 29018129]
[14]
Poels MMF, Vernooij MW, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: An update of the Rotterdam scan study. Stroke 2010; 41(10) (Suppl. 1): S103-6.
[http://dx.doi.org/10.1161/STROKEAHA.110.595181] [PMID: 20876479]
[15]
Vernooij MW, van der Lugt A, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: The Rotterdam Scan Study. Neurology 2008; 70(14): 1208-14.
[http://dx.doi.org/10.1212/01.wnl.0000307750.41970.d9] [PMID: 18378884]
[16]
Werring DJ, Frazer DW, Coward LJ, et al. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain 2004; 127(10): 2265-75.
[http://dx.doi.org/10.1093/brain/awh253] [PMID: 15282216]
[17]
Yakushiji Y, Nishiyama M, Yakushiji S, et al. Brain microbleeds and global cognitive function in adults without neurological disorder. Stroke 2008; 39(12): 3323-8.
[http://dx.doi.org/10.1161/STROKEAHA.108.516112] [PMID: 18688000]
[18]
Dannenberg S, Scheitz JF, Rozanski M, et al. Number of cerebral microbleeds and risk of intracerebral hemorrhage after intravenous thrombolysis. Stroke 2014; 45(10): 2900-5.
[http://dx.doi.org/10.1161/STROKEAHA.114.006448] [PMID: 25116882]
[19]
Altmann-Schneider I, Trompet S, de Craen AJM, et al. Cerebral microbleeds are predictive of mortality in the elderly. Stroke 2011; 42(3): 638-44.
[http://dx.doi.org/10.1161/STROKEAHA.110.595611] [PMID: 21233474]
[20]
Charidimou A, Kakar P, Fox Z, Werring DJ. Cerebral microbleeds and recurrent stroke risk: Systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts. Stroke 2013; 44(4): 995-1001.
[http://dx.doi.org/10.1161/STROKEAHA.111.000038] [PMID: 23493732]
[21]
Charidimou A, Shoamanesh A. Clinical relevance of microbleeds in acute stroke thrombolysis. Neurology 2016; 87(15): 1534-41.
[http://dx.doi.org/10.1212/WNL.0000000000003207] [PMID: 27629086]
[22]
Risk of symptomatic intracerebral hemorrhage after intravenous thrombolysis in patients with acute ischemic stroke and high cerebral microbleed burden: A meta-analysis. JAMA Neurol 2016; 73(6): 675-83.
[http://dx.doi.org/10.1001/jamaneurol.2016.0292] [PMID: 27088650]
[23]
Charidimou A, Turc G, Oppenheim C, et al. Microbleeds, cerebral hemorrhage, and functional outcome after stroke thrombolysis. Stroke 2017; 48(8): 2084-90.
[http://dx.doi.org/10.1161/STROKEAHA.116.012992] [PMID: 28720659]
[24]
Schlemm L, Endres M, Werring DJ, Nolte CH. Benefit of intravenous thrombolysis in acute ischemic stroke patients with high cerebral microbleed burden. Stroke 2020; 51(1): 232-9.
[http://dx.doi.org/10.1161/STROKEAHA.119.027633] [PMID: 31739772]
[25]
Chacon-Portillo MA, Llinas RH, Marsh EB. Cerebral microbleeds shouldn’t dictate treatment of acute stroke: A retrospective cohort study evaluating risk of intracerebral hemorrhage. BMC Neurol 2018; 18(1): 33.
[http://dx.doi.org/10.1186/s12883-018-1029-0] [PMID: 29587638]
[26]
Gregoire SM, Chaudhary UJ, Brown MM, et al. The Microbleed Anatomical Rating Scale (MARS): Reliability of a tool to map brain microbleeds. Neurology 2009; 73(21): 1759-66.
[http://dx.doi.org/10.1212/WNL.0b013e3181c34a7d] [PMID: 19933977]
[27]
Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43(9): 1683-9.
[http://dx.doi.org/10.1212/WNL.43.9.1683] [PMID: 8414012]
[28]
Tang W, Hu J, Zhang H, Wu P, He H. Kappa coefficient: A popular measure of rater agreement. Shanghai Jingshen Yixue 2015; 27(1): 62-7.
[29]
Romero JR, Preis SR, Beiser A, et al. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke 2014; 45(5): 1492-4.
[http://dx.doi.org/10.1161/STROKEAHA.114.004130] [PMID: 24713533]
[30]
Ikram MA, Wieberdink RG, Koudstaal PJ. International epidemiology of intracerebral hemorrhage. Curr Atheroscler Rep 2012; 14(4): 300-6.
[http://dx.doi.org/10.1007/s11883-012-0252-1] [PMID: 22538431]
[31]
Millwood IY, Walters RG, Mei XW, et al. Conventional and genetic evidence on alcohol and vascular disease aetiology: A prospective study of 500 000 men and women in China. Lancet 2019; 393(10183): 1831-42.
[http://dx.doi.org/10.1016/S0140-6736(18)31772-0] [PMID: 30955975]
[32]
Yoo JS, Ryu CH, Kim YS, Kim HJ, Bushnell CD, Kim HY. Homocysteinemia is associated with the presence of microbleeds in cognitively impaired patients. J Stroke Cerebrovasc Dis 2020; 29(12): 105302.
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.105302] [PMID: 32992197]
[33]
Low A, Mak E, Rowe JB, Markus HS, O’Brien JT. Inflammation and cerebral small vessel disease: A systematic review. Ageing Res Rev 2019; 53: 100916.
[http://dx.doi.org/10.1016/j.arr.2019.100916] [PMID: 31181331]
[34]
Shoamanesh A, Preis SR, Beiser AS, et al. Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: Framingham Heart Study. Neurology 2015; 84(8): 825-32.
[http://dx.doi.org/10.1212/WNL.0000000000001279] [PMID: 25632086]
[35]
Kloppenborg RP, Geerlings MI, Visseren FL, et al. Homocysteine and progression of generalized small-vessel disease: The SMART-MR Study. Neurology 2014; 82(9): 777-83.
[http://dx.doi.org/10.1212/WNL.0000000000000168] [PMID: 24477110]
[36]
Derex L, Nighoghossian N, Hermier M, et al. Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc Dis 2004; 17(2-3): 238-41.
[http://dx.doi.org/10.1159/000076123] [PMID: 14718753]
[37]
Lee SH, Bae HJ, Kwon SJ, et al. Cerebral microbleeds are regionally associated with intracerebral hemorrhage. Neurology 2004; 62(1): 72-6.
[http://dx.doi.org/10.1212/01.WNL.0000101463.50798.0D] [PMID: 14718700]
[38]
Akoudad S, Portegies MLP, Koudstaal PJ, et al. Cerebral microbleeds are associated with an increased risk of stroke. Circulation 2015; 132(6): 509-16.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.115.016261] [PMID: 26137955]
[39]
Wilson D, Ambler G, Lee KJ, et al. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: A pooled analysis of individual patient data from cohort studies. Lancet Neurol 2019; 18(7): 653-65.
[http://dx.doi.org/10.1016/S1474-4422(19)30197-8] [PMID: 31130428]
[40]
Wilson D, Charidimou A, Ambler G, et al. Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA. Neurology 2016; 87(14): 1501-10.
[http://dx.doi.org/10.1212/WNL.0000000000003183] [PMID: 27590288]
[41]
Gouw AA, Seewann A, van der Flier WM, et al. Heterogeneity of small vessel disease: A systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011; 82(2): 126-35.
[http://dx.doi.org/10.1136/jnnp.2009.204685] [PMID: 20935330]
[42]
Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. J Neurol 1993; 43: 1683-9.
[43]
Naka H, Nomura E, Takahashi T, et al. Combinations of the presence or absence of cerebral microbleeds and advanced white matter hyperintensity as predictors of subsequent stroke types. AJNR Am J Neuroradiol 2006; 27(4): 830-5.
[PMID: 16611773]
[44]
Lee SH, Bae HJ, Yoon BW, Kim H, Kim DE, Roh JK. Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: Analysis of risk factors for multifocal signal loss lesions. Stroke 2002; 33(12): 2845-9.
[http://dx.doi.org/10.1161/01.STR.0000036092.23649.2E] [PMID: 12468780]
[45]
Haussen DC, Henninger N, Kumar S, Selim M. Statin use and microbleeds in patients with spontaneous intracerebral hemorrhage. Stroke 2012; 43(10): 2677-81.
[http://dx.doi.org/10.1161/STROKEAHA.112.657486] [PMID: 22829545]
[46]
Katsanos AH, Lioutas VA, Charidimou A, et al. Statin treatment and cerebral microbleeds: A systematic review and meta-analysis. J Neurol Sci 2021; 420: 117224.
[http://dx.doi.org/10.1016/j.jns.2020.117224] [PMID: 33183779]
[47]
Knopman DS, Penman AD, Catellier DJ, et al. Vascular risk factors and longitudinal changes on brain MRI: The ARIC study. Neurology 2011; 76(22): 1879-85.
[http://dx.doi.org/10.1212/WNL.0b013e31821d753f] [PMID: 21543737]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy